KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Inventory (2020 - 2025)

Organon has reported Inventory over the past 6 years, most recently at $1.4 billion for Q4 2025.

  • Quarterly results put Inventory at $1.4 billion for Q4 2025, up 6.43% from a year ago — trailing twelve months through Dec 2025 was $1.4 billion (up 6.43% YoY), and the annual figure for FY2025 was $1.4 billion, up 6.43%.
  • Inventory for Q4 2025 was $1.4 billion at Organon, down from $1.5 billion in the prior quarter.
  • Over the last five years, Inventory for OGN hit a ceiling of $1.5 billion in Q3 2025 and a floor of $871.0 million in Q2 2021.
  • Median Inventory over the past 5 years was $1.2 billion (2023), compared with a mean of $1.2 billion.
  • Biggest five-year swings in Inventory: fell 4.25% in 2022 and later surged 34.93% in 2023.
  • Organon's Inventory stood at $915.0 million in 2021, then increased by 9.62% to $1.0 billion in 2022, then skyrocketed by 31.11% to $1.3 billion in 2023, then grew by 0.46% to $1.3 billion in 2024, then rose by 6.43% to $1.4 billion in 2025.
  • The last three reported values for Inventory were $1.4 billion (Q4 2025), $1.5 billion (Q3 2025), and $1.5 billion (Q2 2025) per Business Quant data.